*Maha Saleem Mohammed Ali


Diabetes mellitus is a metabolic disorder characterized by the presence of hyperglycemia due to defective insulin secretion, defective insulin action or both. It is the most common metabolic disorder that occurs during pregnancy. It has two clinical patterns; either gestational or pregestational diabetes. Pregnancy in women with diabetes mellitus is associated with an increased risk of congenital malformations, obstetric complications and neonatal morbidity. This study aimed to evaluate the impact of different types of diabetes mellitus without vascular changes on maternal and fetal outcomes. The study was done at Mosul General hospital - Department of Obstetrics and Gynecology- Mosul /Iraq during the period from September 2018 to September 2019 and included 100 cases of gestational and pregestational diabetic pregnant women. The results showed that mean age of the studied group was (28.7±6.45) ranging from (18 to 41) years and the mean BMI of the studied group was (25.9±3.9) ranging from (18 to 32) and 44% of PGDM and 32% of GDM patients were obese. There was no statistically significant difference in positive family history of diabetes and previous history of congenital fetal malformation, Intra Uterine Fetal Death and gestational diabetes mellitus between the two groups. There was no statistically significant difference in gestational age at delivery and mode of delivery in current pregnancy between the two groups. Both gestational or pregestational showed no statistical difference between maternal and fetal outcomes. It can be concluded from our study that in either diabetes, gestational or pregestational, there was no statistical difference between maternal and fetal outcomes. Optimal control of blood glucose resulted in lower neonatal and maternal complications. Further studies on large geographical scale and larger sample size are required to support our conclusion.

Keywords: Pregestational diabetes; Gestational diabetes; Maternal; Fetal outcomes.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    NOVEMBER 2022 Issue has been successfully launched on 1 NOVEMBER 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction